Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Barrett M James
Relationship:   10% Owner
City:   Baltimore
State:   MD
   
Insider Summary:
  
   
Companies Owned :   45    
Direct Shares   1,977,383    

Indirect Shares

   257,297,662      
Direct Value   $28,409,835    

Indirect Value

   $728,358,999      
Total Shares   259,275,045      
Total Value   $756,768,834      


Aradigm Corp $0 Groupon, Inc. $8,226 Clovis Oncology, Inc. $13 Tesaro, Inc. $0 Audience Inc $0 Workday, Inc. $269,176 Tableau Software Inc $3,479,095 Care.com Inc $3,777 Zosano Pharma Corp $1 Supernus Pharmaceuticals Inc $2,640,268 Vitae Pharmaceuticals, Inc $0 Senseonics Holdings Inc $220,470 Appian Corp $28,816 Bloom Energy Corp $21,759,995 Aradigm Corp $0 Groupon, Inc. $8,226 Clovis Oncology, Inc. $13 Tesaro, Inc. $0 Audience Inc $0 Workday, Inc. $269,176 Tableau Software Inc $3,479,095 Care.com Inc $3,777 Zosano Pharma Corp $1 Supernus Pharmaceuticals Inc $2,640,268 Vitae Pharmaceuticals, Inc $0 Senseonics Holdings Inc $220,470 Appian Corp $28,816 Bloom Energy Corp $21,759,995
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    2    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   2.0   
     Percentage Gain/Loss :
     0.0%
 -49.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Welltek Incorporated WTKND Director 2008-03-07 0 2008-03-07 0    Premium*  
            Aradigm Corp ARDM 10% Owner 2003-12-11 2,905 2003-12-11 0    Premium*  
            Gyre Therapeutics GYRE 10% Owner 2013-12-03 0 2013-12-05 4,563,512    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 2,083,426    Premium*  
            Vonage Holdings Corp VG 10% Owner 2006-05-30 0 2011-03-11 22,793    Premium*  
            Innerworkings Inc INWK 10% Owner 2007-12-11 0 2012-03-28 15,000    Premium*  
            Medimmune Inc MEDI Director 2007-06-18 0 2007-06-18 0    Premium*  
            Echo Global Logistics Inc ECHO 10% Owner 2012-02-29 0 2012-02-28 0    Premium*  
            Groupon, Inc. GRPN 10% Owner 2013-09-13 5,918 2013-09-13 41,260    Premium*  
            Clovis Oncology, Inc. CLVS Director 2017-02-27 861 2017-02-27 861    Premium*  
            Amicus Therapeutics Inc FOLD Director, 10% Owner 2012-03-07 0 2012-03-07 4,584,311    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO 10% Owner 2018-03-06 252 2018-03-06 9,681,381    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 2014-06-06 0 2015-05-07 0    Premium*  
            Audience Inc ADNC 10% Owner 2013-11-04 508 2013-11-05 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-10 1,273 2013-04-10 10,396    Premium*  
            Tableau Software Inc DATA 10% Owner 2014-12-02 20,522 2014-12-02 69,572    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2014-08-15 0 2016-01-12 6,260,851    Premium*  
            Boingo Wireless Inc WIFI 10% Owner 2013-12-11 0 2013-12-11 0    Premium*  
            Glycomimetics Inc GLYC Director, 10% Owner 0 2018-05-10 9,089,041    Premium*  
            Care.com Inc CRCM 10% Owner 2017-11-06 252 2017-11-06 252    Premium*  
            Roka Bioscience, Inc. ROKA Director, 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO Director, 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Viracta Therapeutics Ord Shs VIRX 10% Owner 2014-08-08 0 2014-08-29 4,659,333    Premium*  
            Ardelyx Inc ARDX 10% Owner 2014-12-26 0 2018-05-25 9,169,210    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Zosano Pharma Corp ZSAN 10% Owner 2017-02-13 5 2017-02-13 952,809    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Supernus Pharmaceuticals Inc SUPN Director 2016-03-16 97,355 2016-03-16 115,355    Premium*  
            Vitae Pharmaceuticals, Inc VTAE 10% Owner 2015-07-01 464 2015-07-01 1,134    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2018-09-07 82,978,668    Premium*  
            Kineta Ord Shs KA Director, 10% Owner 2016-02-17 0 2017-12-18 5,554,610    Premium*  
            Senseonics Holdings Inc SENS Director 2019-01-02 512,720 2019-01-02 152,079    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2017-07-03 0 2017-07-03 8,140,138    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2018-02-13 1,015 2018-02-13 1,015    Premium*  
            Bloom Energy Corp BE 10% Owner 2018-07-27 1,333,333 2018-07-27 0    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2018-07-30 0 2018-07-30 2,484,870    Premium*  
* Premium Members only  

Records found :    306         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 11 of 13
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ROKA Roka Bioscience, Inc. Director   –       •       •   2014-07-22 4 A $0.00 $0 I/I 2,828,743 2,833,477 0 -
ROKA Roka Bioscience, Inc. Director   –       •       •   2014-07-22 4 B $12.00 $4,599,996 I/I 383,333 3,216,810 2.25 -
LOXO Loxo Oncology, Inc. Director   –       •       •   2014-08-06 4 B $13.00 $2,999,997 I/I 230,769 1,789,420 2.25 -
LOXO Loxo Oncology, Inc. Director   –       •       •   2014-08-06 4 A $0.00 $0 I/I 1,558,651 1,558,651 0 -
ZSAN Zosano Pharma Corp Director   –       •       •   2015-01-26 3 IO $0.00 $0 D/D 0 5 -
ZSAN Zosano Pharma Corp Director   –       •       •   2015-01-26 3 IO $0.00 $0 I/I 0 1,793,881 -
ZSAN Zosano Pharma Corp Director   –       •       •   2015-01-30 4 B $11.00 $258,027 I/I 23,457 2,158,539 2.25 -
ZSAN Zosano Pharma Corp Director   –       •       •   2015-01-30 4 OE $9.35 $3,190,229 I/I 341,201 2,135,082 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-05-14 4 A $0.00 $0 D/D 287 574 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-05-14 4 A $0.00 $0 I/I 14,110 2,424 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-05-14 4 D $0.00 $0 I/I (1,151,290) 0 0 -
CLVS Clovis Oncology, Inc. Director   –       •      –    2015-05-15 4 S $91.86 $224,039 I/I (2,424) 0 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-06-15 4 A $0.00 $0 I/I 1,120,510 166,986 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-06-15 4 A $0.00 $0 D/D 32,524 32,524 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-06-15 4 D $0.00 $0 I/I (3,921,000) 921,000 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-06-16 4 S $16.85 $928,668 I/I (55,105) 111,881 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-06-17 4 S $16.02 $1,833,603 I/I (111,881) 0 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-11-11 4 A $0.00 $0 I/I 1,426,987 212,650 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-11-11 4 A $0.00 $0 D/D 41,405 73,929 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •       •   2015-11-11 4 D $0.00 $0 I/I (4,993,557) 0 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •      –    2015-11-13 4 S $16.26 $1,625,610 I/I (100,000) 112,650 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •      –    2015-11-16 4 S $16.13 $317,035 I/I (19,650) 93,000 0 -
GLYC Glycomimetics Inc Director   –       •       •   2015-11-16 4 OE $0.33 $3,117 I/I 9,445 4,491,203 0 -
GLYC Glycomimetics Inc Director   –       •       •   2015-11-16 4 S $6.91 $3,123 I/I (452) 4,490,751 0 -
SUPN Supernus Pharmaceuticals ... Director   –       •      –    2015-11-17 4 S $16.71 $835,460 I/I (50,000) 43,000 0 -
  306  Records found
  1   2   3   4   5   6   7   8   9   10   11  12   13      
  Page 11 of 13  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us